Press Releases

December 13, 2016

NantHealth Added to Nasdaq Biotech Index

Read More
December 8, 2016

NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer™ and Phase I – III QUILT Trials Through the U.S. National Institutes of Health’s ClinicalTrials.gov

Read More
December 7, 2016

NantHealth And TransMed Systems Partner to Enable and Inform Community Oncologists of the Most Effective Tools and Technologies for Personalized Cancer Treatments Using GPS Cancer™

Read More
December 6, 2016

NantHealth Announces Exclusive Reseller Agreement for GPS Cancer™ with Oncotest-Teva in Israel

Read More
December 5, 2016

NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus

Read More
November 7, 2016

NantHealth Reports 76% Increase in Total Q3 Net Revenue 2016 vs 2015, Gross Profit Triples

Read More
November 4, 2016

NantHealth to Report 2016 Third-Quarter Financial Results and Host Conference Call on Monday, November 7

Read More
November 3, 2016

NantHealth Announces Global Expansion of GPS Cancer; Partners with Sorgente to Expand Availability of GPS Cancer™ to Italy

Read More
October 27, 2016

NantHealth Expands GPS Cancer™ Coverage Through Partnership with Horizon Blue Cross Blue Shield of New Jersey and COTA

Read More
October 26, 2016

NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment Decisions for Cancer Patients

Read More
Looking for older Press Releases? Check out the full archive here.